Monitoring Low Molecular Weight Heparins at Therapeutic Levels: Dose-Responses of, and Correlations and Differences between aPTT, Anti-Factor Xa and Thrombin Generation Assays

BACKGROUND: Low molecular weight heparins (LMWH’s) are used to prevent and treat thrombosis. Tests for monitoring LMWH’s include anti-factor Xa (anti-FXa), activated partial thromboplastin time (aPTT) and thrombin generation. Anti-FXa is the current gold standard despite LMWH’s varying affinities fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Thomas, Owain, Lybeck, Emanuel, Strandberg, Karin, Tynngård, Nahreen, Schött, Ulf
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4308107/
https://www.ncbi.nlm.nih.gov/pubmed/25625201
http://dx.doi.org/10.1371/journal.pone.0116835

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4308107/
https://www.ncbi.nlm.nih.gov/pubmed/25625201
http://dx.doi.org/10.1371/journal.pone.0116835

Ejemplares similares